Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement, not replace the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Okay, let's unpack this.
Our bodies are incredibly sophisticated energy storage units, but sometimes we focus so much on the fuel in the tank like glucose that we forget about the enormous operation required to turn excess energy into permanent structure.
Today, we're doing a complete deep dive into the biochemistry of fat production.
This is a focused breakdown of fatty acid synthesis, what scientists call lycogenesis and then how those fats are used to create these really potent signaling molecules, the icosanoids.
We're basing all this on a foundational biochemistry text, really trying to give you that under the hood view.
And the big why here could be more relevant.
I mean, fatty acids aren't just energy stores, they're the backbone of every single cell membrane.
Understanding this pathway is crucial because when it goes wrong, you see major diseases.
Think about type one diabetes where the pathway is dramatically inhibited or conditions like obesity where variations in this pathway are key.
Another of the end products, the icosanoids, they regulate everything from pain to blood clotting.
What's truly fascinating to me is the sheer efficiency of the system.
Our sources highlight that this de novo synthesis lets us convert something simple like glucose into a complex 16 carbon fatty acid called palmitate.
We're essentially building these big complex structures from simple two carbon units.
It's just genius how the body handles excess calories.
So to organize this, we're gonna look at two main systems.
First, the core synthesis pathway, how we actually build the fat chain.
And second, the subsequent production of those crucial signaling molecules like the prostaglandins.
And those are the very targets for common drugs you can buy anywhere like aspirin.
All right, let's jump right in.
The main pathway,
de novo synthesis or lipogenesis.
The location is really important here.
The starting material comes from the mitochondria, but the whole construction process happens in the cytosol in tissues like the liver, kidney, brain, and of course adipose tissue.
And the primary raw material, the first building block is acetyl -CoA.
Right, but before the assembly can even begin, we hit this first critical regulatory step.
We have the acetyl -CoA, but you can't just start sticking two carbon units together.
You have to activate the input first.
And this initial highly regulated reaction is the conversion of acetyl -CoA to something called malonyl -CoA.
This step is the chemical gatekeeper of the whole process.
It's catalyzed by an enzyme, acetyl -CoA carboxylase or ACC.
Think of it like this.
It needs special entry ticket, it costs ATP, and it needs the B vitamin biotin to stick a carbon dioxide molecule onto the acetyl -CoA.
If we don't make malonyl -CoA, we just don't make fat.
It's as simple as that.
So that makes ACC maybe the most important enzyme we'll talk about today.
Okay, so once we've paid that energy price and made malonyl -CoA, the building begins.
And the machinery is, well, it's stunning.
The fatty acid synthase complex, or FAS.
And this isn't just a handful of enzymes floating around.
It's a single massive functional unit.
Unmodimer.
Right, a structure with six different enzyme activities, plus this crucial carrier molecule, the acyl carrier protein, the ACP, which sort of holds on to the growing fatty acid chain like a robotic arm.
Exactly.
And the advantage of having this single machine is brilliant.
It's like an entire factory floor compressed into one complex.
All the intermediates are kept close.
You get compartmentalization inside the cell without any actual walls.
And because all the parts are encoded by a single gene, their production is perfectly coordinated.
So how does this fatty acid factory floor actually work?
What's the cycle?
It's an iterative cycle.
First, the FAS complex gets primed with an initial acetyl -CoA to start the chain.
Then the malonyl -CoA units are added one by one.
But here's the key functional insight.
When the malonyl -CoA adds its two carbons, it immediately liberates the TOO that was just added in that first step.
Oh, wow.
So that initial energy investment, the carboxylation, it's not just about activation.
Precisely.
That decarboxylation step releases a burst of energy.
It's highly favorable.
And it acts like this huge chemical lever that just pulls the entire reaction forward.
It ensures elongation goes to completion.
After that, the new molecule undergoes a cycle of modification, a reduction, a dehydration, and other reduction, all powered by NADPH.
And this cycle just repeats six more times until you get the final 16 -carbon chain, palmitate, which is then snipped off by a final enzyme.
That brings us right to logistics.
Because now we know we need to feed this FAS machine with two things,
a fetal -CoA and lots of NADPH.
And that creates two pretty big logistical problems for the cell.
First up, the transport problem.
Acetyl -CoA is made inside the mitochondrial matrix, but it needs to get out into the cytosol for lipogenesis.
And it can't just cross that inner mitochondrial membrane.
It's basically trapped in there.
It is.
And to solve the supply chain issue, the cell uses a really clever workaround called the citrate shuttle.
Inside the mitochondria, acetyl -CoA combines with oxaloacetate, part of the Krebs, cycle to form citrate.
Citrate can cross the membrane using a specific transporter.
Once it's in the cytosol, an enzyme called ATP citrate liase just splits it right back into acetyl -CoA and oxaloacetate, problem solved.
That makes perfect sense.
So citrate isn't just a signal that the Krebs cycle is busy.
It's the actual vehicle carrying the fuel for fat synthesis.
Now what about all that reducing power, that NADPH?
A single palmitate synthesis needs a ton of it.
Where do we get all that hydrogen?
The chief source of NADPH in tissues doing active fat synthesis is the pentose phosphate pathway, or PPP.
And conveniently, it's also running right there in the cytosol next to the FAS complex.
But the cell is so efficient it actually gets a second supply from that citrate shuttle we just mentioned.
Remember the oxaloacetate that was left over when citrate was split?
Well that oxaloacetate can become malate, which is then converted back to pyruvate by the malic enzyme.
And this specific reaction is so important because it generates even more NADPH exactly where it's needed.
It's a beautiful closed loop system.
Okay, logistics solved.
Let's talk regulation.
Because this whole pathway is so tightly managed by our nutritional state.
Short term, it's all about that gatekeeper enzyme again, right?
Acetyl -CoA carboxylase.
Yes, ACC is the cell's allosteric sensor for energy abundance.
It is strongly activated by citrate.
When citrate levels build up in the cytosol, a clear signal, the mitochondria are overloaded.
It forces ACC to shift from an inactive dimer into a highly active long polymer.
It's like flipping a switch to storage mode.
And the negative feedback is just as quick, I assume.
It is.
The finished product, things like palmitoyl -CoA, they act as direct feedback inhibitors.
They signal to ACC to promote its own inactivation through phosphorylation.
But the control doesn't even stop there.
This fat product also inhibits the transporter that lets citrate out of the mitochondria in the first place.
So the finished fat shuts down the enzyme and it stops the main activating signal from even getting into the cytosol.
That's a powerful off switch.
And then if you zoom out to the broader hormonal control, you see covalent modification.
Insulin, for instance, promotes fat synthesis.
It does this through dephosphorylation of ACC.
It removes that inhibitory phosphate group.
Insulin also helps by boosting glucose uptake and activating other necessary enzymes.
And conversely, if you're fasting or under stress, glucagon or epinephrine inhibits synthesis.
They trigger a cascade that activates a kinase, which leads to phosphorylation and rapid inactivation of ACC.
So insulin says store and glucagon says stop storing.
We need this fuel now.
And for long -term control, the body literally changes the size of the factory.
Fatty acid synthase and ACC are called adaptive enzymes.
So if you're well -fed for days, insulin promotes more gene expression.
The cells make more of these proteins.
But during starvation or a high -fat diet,
gene expression is dialed way down.
So we've made palmitate, a C16 saturated fat, but we need longer chains and double wands for all sorts of biological functions.
How do we get there?
Chains can be lengthened further, especially for the very long chain fatty acids needed for things like myelination in the brain.
This happens in the endoplasmic reticulum.
It's a different system, but it also uses melanocoy as the two -carbon donor.
And diversification comes from desaturation introducing double bonds.
The first double bond is almost always placed at the delta nine position by a special desaturase in the ER.
We call it delta nine because we count carbons from the carboxyl in.
This is why we can make things like oleic acid ourselves.
They're non -essential.
But this is where we hit a massive biological limitation, the one that really dictates our nutritional needs.
We have enzymes to put double bonds between that delta nine position and the front of the molecule, but we cannot introduce double bonds beyond the delta nine position, closer to the tail end of the chain.
And that one chemical limitation is why we cannot synthesize linoleic acid, which is an omega -6 fat, and alpha -linoleic acid, an omega -3.
Our bodies have to get them from plants, which do have the necessary enzymes, so they must be in our diet.
They are the essential fatty acids, the EFAs.
And these EFAs are the starting points for entire families of really important fats.
We take linoleic acid, the omega -6 starter, and we build it into the powerful arachidonic acid.
And we take alpha -linoleic acid, the omega -3, and build it into EPA and DHA, which is so critical for brain development.
The clinical relevance is immediate.
EFAs are vital for membrane structure.
DHA is specifically needed for the brain and the retina.
So a deficiency, sometimes seen in infants on specialized IV nutrition, leads to skin lesions and impaired fat transport.
And if a deficiency is suspected, how is that actually confirmed?
Well, the body tries to compensate.
It starts substituting the missing EFAs with non -essential omega -9 fats.
So we use the trinine .tetraena ratio in plasma lipids as a diagnostic tool.
A high ratio means a significant deficiency.
It's also worth a quick mention that trans fats from industrial hydrogenation, they compete with these EFAs and promote negative cardiovascular effects.
So that competition is clinically very relevant.
Okay, let's move to the last and maybe the most potent topic,
the eicosanoids.
This is where fats become these highly active local hormones.
We're talking about prostaglandins, thromboxanes, leukotrienes.
These are incredibly powerful signals derived primarily from that C20 fat we just mentioned, arachidonic.
They are local hormones, meaning they act very quickly, right near where they're made, and then they degrade fast.
Crucially, they aren't stored.
Their synthesis depends entirely on releasing the substrate, arachidonit, from the cell membrane, and that release is catalyzed by an enzyme called phospholipase aereo in response to some kind of stimulus.
Once it's released, arachidonit can go down one of two main paths.
The first is the cyclooxygenase pathway, or COX pathway, which gives us the prostanoids.
The key enzyme here is cyclooxygenase, which has two main forms, COX1 and COX2.
COX1 is sort of always on, doing routine physiological housekeeping.
COX2 is typically inducible.
It's made rapidly in response to inflammation.
This pathway also leads to some fascinating biological antagonism.
In your platelets, the pathway makes thromboxane euro, or TXS.
This causes blood vessels to constrict and platelets to aggregate.
You need it to form a clot.
But in the blood vessel walls themselves, the pathway produces prostacyclin, PGI, and that is a potent inhibitor of aggregation and a vasodilator.
These two are in constant opposition to maintain balance.
Which is exactly why antisides like aspirin are so powerful.
Aspirin at a low dose specifically and irreversibly inhibits COX1 in platelets.
That shuts down thromboxane synthesis and helps prevent clots.
And corticosteroids act even higher up, blocking COX2 expression.
And it's a suicide enzyme, so COX basically destroys itself, which helps switch off the signal really quickly.
The second major pathway is the lipoxygenase pathway.
This gives us the leukotrienes and lipoxins.
The enzyme 5 -lipoxygenase is key here, forming the powerful leukotrienes.
And the clinical consequences here are huge.
A mixture of some of these leukotrienes is known as the slow -reacting substance of anaphylaxis, or SRSA.
They are incredibly potent constrictors of the bronchial airways.
They're major players in inflammatory reactions like asthma, which is why some asthma medications specifically target their synthesis or their receptors.
So to summarize this entire journey, we started with acetyl -CoA trapped in the mitochondria.
We used the citrate shuttle to get it out.
We used acetyl -CoA carboxylase as a regulated gatekeeper to build malonyl -CoA.
Then the FAS assembly line, powered by NADPH, built palmitate.
We then saw how our own biological limits mean we have to get omega -6 and omega -3 fats from our diet.
And finally, those fats are released to become icosinoids, the local hormones that manage everything from pain and inflammation to blood clotting.
So what does this all mean for you?
It means that the type of fat you consume, your dietary fatty acid profile, literally defines your body's potential to regulate these core physiological processes.
Because your body can only use what you give it to synthesize these incredibly potent molecules.
So considering the powerful, often opposing actions of molecules like the clotting agent TXA -RO and the anti -clotting agent PGI, and how the integrity of your brain relies on fats you can't even make yourself, how consciously are you managing that dietary balance right now?
How closely do you think your current intake of essential fats is regulating your baseline inflammatory response?
That's a vital question.
And it's definitely worth exploring further.
Thank you for joining us for this deep dive into the fascinating world of fatty acid and acosinoid biosynthesis.